Prosensa receives £7.5M milestone payment in GSK2402968 Off IIa bother in favour of DMD
Prosensa, the Dutch biopharmaceutical body focusing on RNA modulating therapeutics, has announced that it received a £7.5m milestone payment from GlaxoSmithKline (GSK) as a upshot of achieving a information milestone in its Facet IIa honest hallmark development enquiry of GSK2402968 (PRO051), being developed to usage of Duchenne Husky Dystrophy (DMD) beneath its covenant with GSK. The milestone payment was based upon completion of a remunerative cover give ones opinion of, with no genuine security signals observed.
“Our common inscription to rare diseases is basic to the ascendancy of the programme.”
GSK2402968 (PRO051) is an investigational antisense oligonucleotide which induces exon skipping of exon 51. The six-month statistics from the apparent nickname Status IIa supplement reflect on in 12 patients with DMD, receiving a weekly 6mg/kg systemic delivering nigh subcutaneous injection, compel be presented at the 15th Supranational Congress of the Area Muscle Sorority in Japan, October 12-16. The information wishes be presented next to Dr. Nathalie Goemans, MD, from the Division of Pediatric Neurology, University of Leuven, Belgium.
Covered by their collaboration, Prosensa and GSK take a few to a greater distance late-stage clinical trials underway.
"It is with prodigious zest that we be the spitting image this mix, and other products to usage of DMD, forward-looking with GSK," said Dr. Giles Campion, Chief Medical G-man of Prosensa. "Our common assignment to rare diseases is elemental to the star of the programme."
"I am in seventh heaven with achieving this noted milestone. It is an additional validation and more distant confirmation of our technology and party line as very much as of our first-rate collaboration with GSK," said Hans Schikan, Chief Governmental Tec of Prosensa.
SOURCE Prosensa
Help-Medical.net finds at this phrases:
- SAVOR timi 53 astrazeneca
- fda gv1001
- lisa romano teletracking
- savor-timi 53
- hoya surgical adoptics
- gv1001 pancreatic cancer
No related posts.
Related posts brought to you by Yet Another Related Posts Plugin.
